Cargando…
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
Drug resistance is a major impediment to patient survival and remains the primary cause of unsuccessful cancer therapy. Drug resistance occurs in many tumors and is frequently induced by chemotherapy which triggers a defensive response both in cancerous and cancer-associated cells that constitute th...
Autores principales: | Di Vito Nolfi, Mauro, Vecchiotti, Davide, Flati, Irene, Verzella, Daniela, Di Padova, Monica, Alesse, Edoardo, Capece, Daria, Zazzeroni, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257640/ https://www.ncbi.nlm.nih.gov/pubmed/35814425 http://dx.doi.org/10.3389/fonc.2022.933922 |
Ejemplares similares
-
NF-κB: A Druggable Target in Acute Myeloid Leukemia
por: Di Francesco, Barbara, et al.
Publicado: (2022) -
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
por: Vecchiotti, Davide, et al.
Publicado: (2022) -
Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
por: Flati, Irene, et al.
Publicado: (2023) -
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
por: Verzella, Daniela, et al.
Publicado: (2022) -
Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer
por: Cornice, Jessica, et al.
Publicado: (2021)